Atlas Trials

Rosuvastatin to Decrease Residual Immune Activation in HIV Infection

Clinical trial NCT01874743 · UNKNOWN

Trial details

NCT number
NCT01874743
Sponsor
Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
HIV-1 Infection
Start date
2012-03-01
Primary completion
2013-09-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.